The current share price of Heron Therapeutics Inc. (HRTX) trades actively on the Nasdaq exchange around thirty-two cents per share. Equity valuations shift continuously during market hours based on quarterly product sales disclosures, commercial execution of its acute care and oncology supportive care portfolios, and broader small-cap biotech sector trends. Because micro-cap and low-priced equities can experience sharp intraday volatility, market participants are advised to check live trading terminals for exact real-time quotes.